Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether neo-adjuvant weekly paclitaxel with
carboplatin is better than paclitaxel alone in efficiency and safety in early breast cancer,
and to explore whether ultrasound and magnetic resonance imaging can predict the efficiency
of neo-adjuvant chemotherapy.